Propiedad y actividad de insiders de Cardiff Oncology, Inc. (CRDF): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.35 |
| Capitalización | $104M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $37.9M | $8.2M | $11.5M | $10.2M | $131.0M | $11.9M | $16.3M | $21.7M | $51.5M | $17.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $128.9M | $88.9M | $53.2M | $40.3M | $40.8M |
| Cuentas por Cobrar | $100460 | $77095 | $167755 | $203480 | $320000 | $535000 | $771000 | $288000 | $773000 | $182000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $39.0M | $9.5M | $12.8M | $11.4M | $133.4M | $146.1M | $111.3M | $77.4M | $95.1M | $60.1M |
| Inmovilizado Material | $3.8M | $2.4M | $1.3M | $1.6M | $967000 | $3.2M | $3.5M | $2.9M | $2.1M | $1.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $44.0M | $12.3M | $14.2M | $13.1M | $134.7M | $149.5M | $116.2M | $81.6M | $97.2M | $61.9M |
| Cuentas por Pagar | $1.1M | $825244 | $664840 | $656304 | $1.4M | $1.4M | $2.0M | $2.0M | $4.8M | $8.1M |
| Deuda a Corto | $2.4M | $1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $7.8M | $3.9M | $3.0M | $4.8M | $6.1M | $6.6M | $7.8M | $10.4M | $13.4M | $16.4M |
| Deuda a Largo | $14.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $24.2M | $5.8M | $4.1M | $5.8M | $6.6M | $9.1M | $9.8M | $11.9M | $14.2M | $16.5M |
| Reservas | -$148.1M | -$173.0M | -$192.2M | -$208.9M | -$231.5M | -$259.8M | -$298.1M | -$339.5M | -$384.2M | -$430.0M |
| Patrimonio Neto | $19.8M | $6.5M | $10.1M | $7.3M | $128.2M | $140.4M | $106.3M | $69.7M | $82.9M | $45.4M |
| Deuda Total | $16.5M | $1.3M | 0 | $1.7M | $869000 | $3.1M | $2.7M | $2.1M | $1.5M | $832000 |
| Deuda Neta | -$21.4M | -$6.9M | -$11.5M | -$8.5M | -$130.1M | -$137.7M | -$102.6M | -$72.7M | -$90.2M | -$57.5M |
| Capital Circulante | $31.2M | $5.5M | $9.8M | $6.6M | $127.2M | $139.6M | $103.5M | $67.0M | $81.6M | $43.7M |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 3.30 |
Rentabilidad
| Rentabilidad sobre capital | -103.08% |
| Rentabilidad sobre capital invertido | -156.60% |
| Rentabilidad sobre activos | -107.29% |
| Margen bruto | 100.00% |
| Margen operativo | -8320.08% |
| Margen neto | -7884.06% |
Empresas relacionadas: APLT · CRBP · ELTX · FBRX · IPHA · MIST · MOLN
Explorar sector: Healthcare · Biotechnology
Más secciones de CRDF: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones